BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 27549091)

  • 1. Gonadotropin-releasing hormone agonist with add-back treatment is as effective and tolerable as dienogest in preventing pain recurrence after laparoscopic surgery for endometriosis.
    Lee DY; Lee JY; Seo JW; Yoon BK; Choi D
    Arch Gynecol Obstet; 2016 Nov; 294(6):1257-1263. PubMed ID: 27549091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gonadotrophin-releasing hormone analogue or dienogest plus estradiol valerate to prevent pain recurrence after laparoscopic surgery for endometriosis: a multi-center randomized trial.
    Granese R; Perino A; Calagna G; Saitta S; De Franciscis P; Colacurci N; Triolo O; Cucinella G
    Acta Obstet Gynecol Scand; 2015 Jun; 94(6):637-45. PubMed ID: 25761587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of long-term use of combined oral contraceptive after gonadotropin-releasing hormone agonist plus add-back therapy versus dienogest to prevent recurrence of ovarian endometrioma after surgery.
    Seo JW; Lee DY; Kim SE; Yoon BK; Choi D
    Eur J Obstet Gynecol Reprod Biol; 2019 May; 236():53-57. PubMed ID: 30884336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dienogest compared with gonadotropin-releasing hormone agonist after conservative surgery for endometriosis.
    Takaesu Y; Nishi H; Kojima J; Sasaki T; Nagamitsu Y; Kato R; Isaka K
    J Obstet Gynaecol Res; 2016 Sep; 42(9):1152-8. PubMed ID: 27225336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dienogest vs GnRH agonists as postoperative therapy after laparoscopic eradication of deep infiltrating endometriosis with bowel and parametrial surgery: a randomized controlled trial.
    Ceccaroni M; Clarizia R; Liverani S; Donati A; Ceccarello M; Manzone M; Roviglione G; Ferrero S
    Gynecol Endocrinol; 2021 Oct; 37(10):930-933. PubMed ID: 34036845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maintenance therapy with dienogest following gonadotropin-releasing hormone agonist treatment for endometriosis-associated pelvic pain.
    Kitawaki J; Kusuki I; Yamanaka K; Suganuma I
    Eur J Obstet Gynecol Reprod Biol; 2011 Aug; 157(2):212-6. PubMed ID: 21474232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term medical management of endometriosis with dienogest and with a gonadotropin-releasing hormone agonist and add-back hormone therapy.
    Bedaiwy MA; Allaire C; Alfaraj S
    Fertil Steril; 2017 Mar; 107(3):537-548. PubMed ID: 28139239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical efficacy and safety of gonadotropin releasing hormone agonist combined with estrogen-dydrogesteronea in treatment of endometriosis].
    Long QQ; Zhang SF; Han Y; Chen H; Li XL; Hua KQ; Hu WG
    Zhonghua Fu Chan Ke Za Zhi; 2010 Apr; 45(4):247-51. PubMed ID: 20646533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of effect of preoperative dienogest and gonadotropin-releasing hormone agonist administration on laparoscopic cystectomy for ovarian endometriomas.
    Ozaki R; Kumakiri J; Jinushi M; Ikuma S; Murakami K; Kawasaki Y; Kitade M
    Arch Gynecol Obstet; 2020 Oct; 302(4):969-976. PubMed ID: 32661756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Add-back therapy in the treatment of endometriosis-associated pain.
    Zupi E; Marconi D; Sbracia M; Zullo F; De Vivo B; Exacustos C; Sorrenti G
    Fertil Steril; 2004 Nov; 82(5):1303-8. PubMed ID: 15533351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of Post-Operative Medication to Prevent Recurrence of Endometrioma: Cyclic Oral Contraceptive (OC) After Gonadotropin-Releasing Hormone (GnRH) Agonist Versus Dienogest.
    Choi SH; Kim SE; Lim HH; Lee DY; Choi D
    J Korean Med Sci; 2022 Jul; 37(26):e207. PubMed ID: 35790209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficacy and tolerability of short-term low-dose estrogen-only add-back therapy during post-operative GnRH agonist treatment for endometriosis.
    Kim NY; Ryoo U; Lee DY; Kim MJ; Yoon BK; Choi D
    Eur J Obstet Gynecol Reprod Biol; 2011 Jan; 154(1):85-9. PubMed ID: 20832162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postoperative administration of dienogest plus estradiol valerate versus levonorgestrel-releasing intrauterine device for prevention of pain relapse and disease recurrence in endometriosis patients.
    Morelli M; Sacchinelli A; Venturella R; Mocciaro R; Zullo F
    J Obstet Gynaecol Res; 2013 May; 39(5):985-90. PubMed ID: 23551827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of different add-back regimens on hypoestrogenic problems by postoperative gonadotropin-releasing hormone agonist treatment in endometriosis.
    Lee DY; Park HG; Yoon BK; Choi D
    Obstet Gynecol Sci; 2016 Jan; 59(1):32-8. PubMed ID: 26866033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dienogest is as effective as triptorelin in the treatment of endometriosis after laparoscopic surgery: results of a prospective, multicenter, randomized study.
    Cosson M; Querleu D; Donnez J; Madelenat P; Konincks P; Audebert A; Manhes H
    Fertil Steril; 2002 Apr; 77(4):684-92. PubMed ID: 11937116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the effectiveness of Dienogest with medroxyprogesterone acetate in the treatment of pelvic pain and recurrence of endometriosis after laparoscopic surgery.
    Vahid-Dastjerdi M; Hosseini R; Rodi H; Rastad H; Hosseini L
    Arch Gynecol Obstet; 2023 Jul; 308(1):149-155. PubMed ID: 36995381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-dose add-back therapy during postoperative GnRH agonist treatment.
    Tsai HW; Wang PH; Huang BS; Twu NF; Yen MS; Chen YJ
    Taiwan J Obstet Gynecol; 2016 Feb; 55(1):55-9. PubMed ID: 26927249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective randomized study comparing the GnRH-agonist leuprorelin acetate and the gestagen lynestrenol in the treatment of severe endometriosis.
    Regidor PA; Regidor M; Schmidt M; Ruwe B; Lübben G; Förtig P; Kienle E; Schindler AE
    Gynecol Endocrinol; 2001 Jun; 15(3):202-9. PubMed ID: 11447732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postoperative administration of dienogest for suppressing recurrence of disease and relieving pain in subjects with ovarian endometriomas.
    Adachi K; Takahashi K; Nakamura K; Otake A; Sasamoto N; Miyoshi Y; Shioji M; Yamamoto Y; Fujitani M; Wakimoto A; Tokuhira A; Kobayashi E; Yoshimura A; Sawada K; Kimura T
    Gynecol Endocrinol; 2016 Aug; 32(8):646-649. PubMed ID: 26890948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term treatment of endometriosis with dienogest: retrospective analysis of efficacy and safety in clinical practice.
    Römer T
    Arch Gynecol Obstet; 2018 Oct; 298(4):747-753. PubMed ID: 30076546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.